Area of Practice Haematology and Oncology
Specialist Interests

Management of Lymphoma, Chronic Lymphatic Leukaemia and other lymphoproliferative disorders

Professional Profile

Dr Rassam Qualified in 1980 from the University of Baghdad. In 1986 he arrived to the UK on a scholarship for post-graduate training in haematology. He has been a Registrar at the Royal Free Hospital, London and Edgware General Hospital and a Senior Registrar and University of London Lecturer at St Bartholomew’s Hospital, University College Hospital and Hospital for Sick Children at Great Ormond Street. As a senior registrar, he conducted research into immune reconstitution following stem cell transplantation in children with severe combined immune deficiency. He received his Membership of the Royal College of Physicians and the Royal College of Pathologists in 1989 and 1992 respectively and was elected as Fellow of both colleges in 1997 and 1999.

Dr Rassam has a special interest in the management of lymphoid malignancies and in research into the immune mechanisms and therapy of cancer. In 1997 he was awarded The Microscopical Society of Great Britain and Ireland Fellowship to study the technology and isolation of tumour infiltrating lymphocytes at Harvard University in the USA. Following his return, he established a research laboratory at Queen Mary’s Hospital to study the role of the immune system in lymphatic cancer and has presented his findings in National and International meetings. Subsequently, he was awarded two research grants from the Elimination of Leukaemia Fund and Ortho-Biotech Pharmaceuticals to take his research further into non-Hodgkin’s Lymphoma in collaboration with the Rayne Institute and King’s College Hospital, London. This has led to an internationally recognised study of gene expression profiling presented in an oral session at the American Society of Haematology Meeting December 2012 and in the International Conference of Malignant Lymphoma in June 2013. These are internationally the largest and highest rated meetings in the field where a novel tumour growth pathway was identified in follicular lymphoma.

He is an active member of the low and high grade lymphoma subgroups of the National Cancer Research Institute (NCRI), the British Society of Haematology and the American Society of Hematology. He is an examiner and appointment advisory officer for the Royal College of Pathologists. He is the author of a number of several NCRI clinical trial proposals in lymphoma and Waldenstrom’s Macroglobulinaemia, He is a member of the British Society of Haematology  Waldenstrom’s Macroglobulinaemia task force, an author of the National treatment guidelines in this disorder and responsible for the relapsed trials in this disorder. Locally, he is the principal investigator for many trials in lymphoma and CLL. He was president of the West Kent Medico-Chirurgical Society in 2012.